> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Sun Pharma Glaucoma Drug Approved
- URL: https://www.fdaweb.com/sun-pharma-glaucoma-drug-approved/
- Published: 2018-09-14T12:00:00.000Z
- Updated: 2026-09-15T00:32:04.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142358

FDA has approved a Sun Pharmaceutical Industries NDA for Xelpros (latanoprost ophthalmic emulsion) 0.005% for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company says Xelpros is the only form of latanoprost that is not formulated with benzalkonium chloride, a preservative commonly used in topical ocular preparations.

Approval was based on data from a randomized, controlled clinical trials of patients with open-angle glaucoma or ocular hypertension with a mean baseline intraocular pressure of 23-26 mmHg. Data showed that Xelpros lowered pressure by a mean of up to 6-8 mmHg, the company says.